From Name:
From Email:
To Name:
To Email:

Optional Message:

Genomic era reaches pediatric oncology

from OncLive

The relative rarity of pediatric cancers has hampered the work of uncovering their causes and developing new therapies, but efforts to expand the use of genomic and biomarker testing are beginning to provide new options for children and their families, as well as more information to help tailor therapeutic plans. In particular, investigators are looking to target markers that may occur in multiple tumor types in hopes of finding better treatments for recurring and refractory disease and for rare cancers that carry poor prognoses. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063